Combination of oxaliplatin and β-carotene suppresses colorectal cancer by regulating cell cycle, apoptosis, and cancer stemness in vitro
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES Colorectal cancer (CRC) is the third most common cancer worldwide with a high recurrence rate. Oxaliplatin (OXA) resistance is one of the major reasons hindering CRC therapy. β-Carotene (BC) is a provitamin A and is known to have antioxidant and anticancer effects. However, the combined effect of OXA and BC has not been investigated. Therefore, this study investigated the anticancer effects and mechanism of the combination of OXA and BC on CRC. MATERIALS/METHODS In the present study, the effects of the combination of OXA and BC on cell viability, cell cycle arrest, and cancer stemness were investigated using HCT116, HT29, OXA-resistant cells, and human CRC organoids. RESULTS The combination of OXA and BC enhanced apoptosis, G2/M phase cell cycle arrest, and inhibited cancer cell survival in human CRC resistant cells and CRC organoids without toxicity in normal organoids. Cancer stem cell marker expression and self-replicating capacity were suppressed by combined treatment with OXA and BC. Moreover, this combined treatment upregulated apoptosis and the stem cell-related JAK/STAT signaling pathway. CONCLUSIONS Our results suggest a novel potential role of BC in reducing resistance to OXA, thereby enhances the anticancer effects of OXA. This enhancement is achieved through the regulation of cell cycle, apoptosis, and stemness in CRC.
Abstract
BACKGROUND/OBJECTIVES Colorectal cancer (CRC) is the third most common cancer worldwide with a high recurrence rate. Oxaliplatin (OXA) resistance is one of the major reasons hindering CRC therapy. β-Carotene (BC) is a provitamin A and is known to have antioxidant and anticancer effects. However, the combined effect of OXA and BC has not been investigated. Therefore, this study investigated the anticancer effects and mechanism of the combination of OXA and BC on CRC. MATERIALS/METHODS In the present study, the effects of the combination of OXA and BC on cell viability, cell cycle arrest, and cancer stemness were investigated using HCT116, HT29, OXA-resistant cells, and human CRC organoids. RESULTS The combination of OXA and BC enhanced apoptosis, G2/M phase cell cycle arrest, and inhibited cancer cell survival in human CRC resistant cells and CRC organoids without toxicity in normal organoids. Cancer stem cell marker expression and self-replicating capacity were suppressed by combined treatment with OXA and BC. Moreover, this combined treatment upregulated apoptosis and the stem cell-related JAK/STAT signaling pathway. CONCLUSIONS Our results suggest a novel potential role of BC in reducing resistance to OXA, thereby enhances the anticancer effects of OXA. This enhancement is achieved through the regulation of cell cycle, apoptosis, and stemness in CRC.
참고문헌 (31)
- Jung KW, "Prediction of cancer incidence and mortality in Korea, 2022", Cancer Res Treat, 54, pp.345~351 (2022)
- Hammond WA, "Pharmacologic resistance in colorectal cancer : a review", Ther Adv Med Oncol, 8, pp.57~84 (2016)
- Nagourney RA, "Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin", Eur J Surg Oncol, 47, pp.738~742 (2021)
- Siddik ZH, "Cisplatin : mode of cytotoxic action and molecular basis of resistance", Oncogene, 22, pp.7265~7279 (2003)
- Clevers H, "The cancer stem cell : premises, promises and challenges", Nat Med, 17, pp.313~319 (2011)
- Yang Z, "Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210", Cell Oncol(Dordr), 43, pp.123~136 (2020)
- Zhang HL, "c-Myc maintains the self-renewal and chemoresistance properties of colon cancer stem cells", Oncol Lett, 17, pp.4487~4493 (2019)
- Tang S, "Association analyses of the JAK", STAT signaling pathway with the progression and prognosis of colon cancer, 2019, pp.17, 159~164
- Xiong W, "Dentatin exerts anticancer effects on human colon cancer cell lines via cell cycle arrest, autophagy, inhibition of cell migration and JAK", STAT signalling pathway, 2019, pp.24, 1488~1493
- Houssein M, "Cell death by gallotannin is associated with inhibition of the JAK", STAT pathway in human colon cancer cells, 2020, pp.92, 100589~
- Taylor PR, "Prevention of esophageal cancer : the nutrition intervention trials in Linxian, China. Linxian Nutrition Intervention Trials Study Group", Cancer Res, 54, pp.2029~ (1994)
- Palozza P, "Induction of cell cycle arrest and apoptosis in human colon adenocarcinoma cell lines by beta-carotene through down-regulation of cyclin A and Bcl-2 family proteins", Carcinogenesis, 23, pp.11~18 (2002)
- Cui Y, "Beta-carotene induces apoptosis and up-regulates peroxisome proliferator-activated receptor gamma expression and reactive oxygen species production in MCF-7 cancer cells", Eur J Cancer, 43, pp.2590~2601 (2007)
- Lim JY, "B-carotene inhibits neuroblastoma tumorigenesis by regulating cell differentiation and cancer cell stemness", Biochem Biophys Res Commun, 450, pp.1475~1480 (2014)
- Zhang X, "Carotenoids inhibit proliferation and regulate expression of peroxisome proliferators-activated receptor gamma(PPARγ)in K562 cancer cells", Arch Biochem Biophys, 512, pp.96~106 (2011)
- Ngoc NB, "Suppressive effects of lycopene and β-carotene on the viability of the human esophageal squamous carcinoma cell line EC109", Oncol Lett, 15, pp.6727~6732 (2018)
- Lee HA, "Effect of β-carotene on cancer cell stemness and differentiation in SK-N-BE(2)C neuroblastoma cells", Oncol Rep, 30, pp.1869~1877 (2013)
- Lee KE, "β-carotene regulates cancer stemness in colon cancer in vivo and in vitro", Nutr Res Pract, 16, pp.161~172 (2022)
- Franken NA, "Clonogenic assay of cells in vitro", Nat Protoc, 1, pp.2315~2319 (2006)
- Kim E, "Phyllodulcin, a natural functional sweetener, improves diabetic metabolic changes by regulating hepatic lipogenesis, inflammation, oxidative stress, fibrosis, and gluconeogenesis in db", db mice, 2018, pp.42, 1~11
- Cristobal A, "Personalized proteome profiles of healthy and tumor human colon organoids reveal both individual diversity and basic features of colorectal cancer", Cell Reports, 18, pp.263~274 (2017)
- Michels BE, "Human colon organoids reveal distinct physiologic and oncogenic Wnt responses", J Exp Med, 216, pp.704~720 (2019)
- Howells LM, "Comparison of oxaliplatin-and curcumin-mediated antiproliferative effects in colorectal cell lines", Int J Cancer, 121, pp.175~183 (2007)
- Palozza P, "Beta-carotene downregulates the steady-state and heregulin-alpha-induced COX-2 pathways in colon cancer cells", J Nutr, 135, pp.129~136 (2005)
- Upadhyaya KR, "Cell cycle regulation and induction of apoptosis by beta-carotene in U937 and HL-60 leukemia cells", J Biochem Mol Biol, 40, pp.1009~1015 (2007)
- Sowmya Shree G, "β-carotene at physiologically attainable concentration induces apoptosis and down-regulates cell survival and antioxidant markers in human breast cancer(MCF-7)cells", Mol Cell Biochem, 436, pp.1~12 (2017)
- Demols A, "Gemcitabine and oxaliplatin(GEMOX)in gemcitabine refractory advanced pancreatic adenocarcinoma : a phase II study", Br J Cancer, 94, pp.481~485 (2006)
- Kim D, "Effects of β-carotene on expression of selected microRNAs, histone acetylation, and DNA methylation in colon cancer stem cells", J Cancer Prev, 24, pp.224~232 (2019)
- Xiong H, "Inhibition of JAK1, 2", STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells, 2008, pp.10, 287~297
- Aggarwal BB, "Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer : modern target but ancient solution", Ann N Y Acad Sci, 1091, pp.151~169 (2006)
- Yu L, "Picrocrocin exhibits growth inhibitory effects against SKMEL-2 human malignant melanoma cells by targeting JAK", STAT5 signaling pathway, cell cycle arrest and mitochondrial mediated apoptosis, 2018, pp.23, 1163~1168
